Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income taxes

Note 20. Income taxes

The following table presents the components of the loss from continuing operations before income taxes:

For the years ended December 31, 

    

2022

    

2021

    

2020

Domestic

$

(521,302)

$

(15,183)

$

(14,107)

Foreign

 

 

 

Loss from Continuing Operations before Income Taxes

$

(521,302)

$

(15,183)

$

(14,107)

The following table presents the components of income tax benefit (expense):

As of December 31, 

    

2022

    

2021

    

2020

Current:

  

  

  

US Federal

$

$

$

US State

 

(789)

 

(254)

 

Foreign

 

 

 

Total current benefit (expense)

$

(789)

$

(254)

$

Deferred:

 

  

 

  

 

  

US Federal

$

12,538

$

$

US State

 

 

 

Foreign

 

 

 

Total deferred benefit

 

12,538

 

 

Total benefit (expense) for income taxes

$

11,749

$

(254)

$

The following table presents the tax effects of temporary differences and tax loss and credit carry forwards that give rise to significant portions of deferred tax assets and liabilities:

As of December 31, 

    

2022

    

2021

Deferred income tax assets:

  

  

Net operating loss carryforwards

$

150,167

$

65,681

Research and development credit carryforwards

 

1,063

 

1,119

Long-term investments

 

 

3,402

Operating lease liabilities

 

5,178

 

1,454

Stock option expense

 

17,422

 

15,827

Bitcoin assets

 

29,111

 

11,403

Intangible assets

6,501

Other assets

1,330

Deferred revenue

4,595

Total deferred tax assets

 

215,367

 

98,886

Valuation allowance

 

(108,060)

 

(61,609)

Net deferred tax assets

 

107,307

 

37,277

Deferred income tax liabilities:

 

  

 

  

Derivative asset

 

(22,678)

 

(5,477)

Property and equipment and other

 

(84,629)

 

(31,800)

Net deferred tax assets (liabilities)

$

$

The Company has approximately $645.9 million and $394.0 million of federal and state tax Net Operating Losses (“NOLs”), respectively, that may be available to offset future taxable income. Federal and state net operating loss carryforwards of $181.4 million and $369.8 million, respectively, if not utilized, expire between 2026 and 2037. Under the Tax Cuts and Jobs Act, $465.5 million federal and $24.2 million state NOLs incurred after December 31, 2017 are carried forward indefinitely, but may be limited in utilization to 80% of taxable income.

Furthermore, as a result of changes in the ownership of our common stock and changes in our business operations, our ability to use our federal NOLs may be limited under Internal Revenue Code Section 382 and 383. State NOLs are subject to similar limitations in many cases. As a result, our substantial NOLs may not have any value to the Company.

The statute of limitations for assessment by the IRS and state tax authorities is open for tax years ending December 31, 2018 through 2022, although carryforward attributes that were generated prior to tax year 2017 may still be adjusted upon examination by the IRS or state tax authorities if they either have been or will be used in a future period. Currently, no federal or state income tax returns are under examination by the respective taxing authorities.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and taxing strategies in making this assessment. In case the deferred tax assets will not be realized in future periods, the Company has provided a valuation allowance for the full amount of the deferred tax assets as of December 31, 2022 and 2021. The valuation allowance increased by approximately $46.4 million during the year ended December 31, 2022.

The following table reconciles the tax expense (benefit) based on the U.S. federal statutory rate with actual tax expense (benefit):

For the years ended December 31, 

2022

2021

2020

Statutory federal income tax expense (benefit)

    

$

(109,376)

    

$

(3,188)

    

$

(2,660)

State taxes, net of federal tax expense (benefit)

 

(3,403)

 

67

 

(471)

Goodwill impairment

 

64,295

 

 

(45)

Contingent payment

(12,538)

Stock compensation

(2,904)

Other nondeductible expenses

11,433

1,732

Tax return to provision true-up

 

(9,026)

 

67

 

(8,737)

State tax rate change

 

3,321

 

(1,908)

 

2,231

Other

 

 

 

Change in valuation allowance

 

46,449

 

3,484

 

9,682

Income taxes expense (benefit)

$

(11,749)

$

254

$

The Company has not identified any uncertain tax positions requiring a reserve as of December 31, 2022 and 2021. The Company’s policy is to recognize interest and penalties that would be assessed in relation to the settlement value of unrecognized tax benefits as a component of income tax expense. The Company did not accrue either interest or penalties for the years ended December 31, 2022 and 2021.

The Company is subject to U.S. federal income tax and primarily Florida, Colorado, Louisiana, and Texas state income tax. The Company has not been under tax examination in any jurisdiction for the years ended December 31, 2022 and 2021.